Gabitril
Links shared publicly online about this topic
FDA approves Cephalon's REMS for GABITRIL
news-medical.net — “Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.” View full resource at news-medical.net
Most Recently Shared on October 15, 2010 at 9:13 am By:
Epilepsy News: FDA approves Cephalon's REMS for GABITRIL: Cephalon, Inc. today announced that a Risk Evaluation an... http://bit.ly/c5l1ZP
FDA approves REMS for Gabitril - MPR
empr.com — “The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) for the antiepileptic drug (AED) Gabitril (tiagabine hydrochloride, from Cephalon).” View full resource at empr.com
Most Recently Shared on October 15, 2010 at 2:06 pm By:
MPR News: FDA approves REMS for Gabitril: The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) fo... http://bit.ly/bz7JDu
Cephalon Gabitril REMS gets FDA approval - Pharmaceutical Business Review
packaging.pharmaceutical-business-review.com — “Cephalon said that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication Gabitril (tiagabine hydrochloride) has been appro” View full resource at packaging.pharmaceutical-business-review.com
Most Recently Shared on October 15, 2010 at 6:49 am By:
Cephalon Gabitril REMS gets FDA approval http://goo.gl/bMIE #pharmaceutical #news
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Epilepsy news and research via News-Medical.Net
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Hill Rick
News Twitter and Twitter Lover.
Advertisement
